(Q53223248)

English

Inhibition of cholinesterase-associated aryl acylamidase activity by anticholinesterase agents: focus on drugs potentially effective in Alzheimer's disease.

scientific article published in May 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/9634011

Inhibition of cholinesterase-associated aryl acylamidase activity by anticholinesterase agents: focus on drugs potentially effective in Alzheimer's disease. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/9634011

author name string

Costagli C

1

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/9634011

Galli A

2

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/9634011

language of work or name

0 references

publication date

1 May 1998

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/9634011

Biochemical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/9634011

55

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/9634011

10

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/9634011

1733-1737

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/9634011

Noncholinergic functions of cholinesterases.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900676-X

7 January 2021

Non-classical actions of cholinesterases: role in cellular differentiation, tumorigenesis and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900676-X

7 January 2021

Serotonin-sensitive aryl acylamidase activity of acetylcholinesterase

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900676-X

7 January 2021

The identity of the serotonin-sensitive aryl acylamidase with acetylcholinesterase from human erythrocytes, sheep basal ganglia and electric eel.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900676-X

7 January 2021

The aryl acylamidases and their relationship to cholinesterases in human serum, erythrocyte and liver

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900676-X

7 January 2021

Cholinesterases display genuine arylacylamidase activity but are totally devoid of intrinsic peptidase activities

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900676-X

7 January 2021

Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900676-X

7 January 2021

Anomalous molecular form of acetylcholinesterase in cerebrospinal fluid in histologically diagnosed Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900676-X

7 January 2021

Differential inhibition of acetylcholinesterase molecular forms in normal and Alzheimer disease brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900676-X

7 January 2021

A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900676-X

7 January 2021

Tacrine alters the secretion of the beta-amyloid precursor protein in cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900676-X

7 January 2021

Differential effect of tacrine and physostigmine on the secretion of the beta-amyloid precursor protein in cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900676-X

7 January 2021

Protease inhibitors and indoleamines selectively inhibit cholinesterases in the histopathologic structures of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900676-X

7 January 2021

A new and rapid colorimetric determination of acetylcholinesterase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900676-X

7 January 2021

Comparison of the pharmacokinetics of E2020, a new compound for Alzheimer's disease, in healthy young and elderly subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900676-X

7 January 2021

Huperzine A ameliorates the spatial working memory impairments induced by AF64A.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900676-X

7 January 2021

Interaction of fluorescence probes with acetylcholinesterase. Site and specificity of propidium binding

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2897%2900676-X

7 January 2021

Identifiers

10.1016/S0006-2952(97)00676-X

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/9634011

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 May 2018

http://europepmc.org/abstract/MED/9634011

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53223248&oldid=2071703044"